Drug Shortage Report for INNOHEP

Last updated on 2020-03-10 History
Report ID 83435
Drug Identification Number 02358166
Brand name INNOHEP
Common or Proper name tinzaparin sodium
Company Name LEO PHARMA INC
Market Status MARKETED
Active Ingredient(s) TINZAPARIN SODIUM
Strength(s) 10000UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 10 x 0.45mL
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-07
Estimated end date 2020-04-13
Actual end date 2020-03-09
Shortage status Resolved
Updated date 2020-03-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3389 STEELES AVENUE EAST, SUITE 110
TORONTO, ONTARIO
CANADA M2H 3S8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2020-03-10 English Compare
v14 2020-03-09 French Compare
v13 2020-03-09 English Compare
v12 2020-02-07 French Compare
v11 2020-02-07 English Compare
v10 2019-11-12 French Compare
v9 2019-11-12 English Compare
v8 2019-08-28 French Compare
v7 2019-08-28 English Compare
v6 2019-07-09 French Compare
v5 2019-07-09 English Compare
v4 2019-05-15 French Compare
v3 2019-05-15 English Compare
v2 2019-05-08 French Compare
v1 2019-05-08 English Compare

Showing 1 to 15 of 15